Cargando…

The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication

Background: Few studies have attempted to assess the effectiveness of formulary management in reducing the antipsychotic costs and utilization across U.S. state Medicaid programs, despite concerns about the potential impact of such formulary management on Medicaid patient health outcomes. Objectives...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frois, Christian, O’Connell, Thomas, Pesa, Jacqueline, Fastenau, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2013
Materias:	Neurological Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341852/ https://www.ncbi.nlm.nih.gov/pubmed/34430660 http://dx.doi.org/10.36469/9853

Ejemplares similares

Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting
por: Farr, Amanda M., et al.
Publicado: (2014)

Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With Schizophrenia
por: Kozma, Chris, et al.
Publicado: (2016)

Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
por: Pesa, Jacqueline A., et al.
Publicado: (2015)

Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular Atrophy
por: Tan, Hiangkiat, et al.
Publicado: (2019)

Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular Atrophy
por: Tan, Hiangkiat, et al.
Publicado: (2019)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV
por: Dunn, Keith, et al.
Publicado: (2018)

Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
por: Bhatta, Madhav P., et al.
Publicado: (2021)

The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis
por: Pardo, Gabriel, et al.
Publicado: (2022)

Using Propensity Score Matching Technique to Estimate Utilization and Costs of General Practitioners’ Services associated with Alzheimer’s Disease
por: Sharma, Rajan, et al.
Publicado: (2016)

Methadone Prescribing and Overdose and the Association with Medicaid Preferred Drug List Policies — United States, 2007–2014
por: Faul, Mark, et al.
Publicado: (2017)

Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists
por: Volerman, Anna, et al.
Publicado: (2022)

Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
por: Lafeuille, Marie-Hélène, et al.
Publicado: (2013)

Multiple Comorbidities, Psychiatric Disorders, Healthcare Resource Utilization and Costs Among Adults with Essential Tremor: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Medicaid Highlights: Trends in Medicaid Prescribed Drug Expenditures and Utilization
por: Tepper, Carl D., et al.
Publicado: (2004)

Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia
por: Noordsy, Douglas L, et al.
Publicado: (2010)

Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review
por: Saber, Wael K, et al.
Publicado: (2022)

Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
por: Xie, Lin, et al.
Publicado: (2013)

Management of Juvenile Myasthenia Gravis
por: O'Connell, Karen, et al.
Publicado: (2020)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson’s Disease
por: Thach, Andrew, et al.
Publicado: (2021)

Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid
por: Kan, Hong J., et al.
Publicado: (2013)

Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients
por: Kamat, Siddhesh A, et al.
Publicado: (2015)

An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures
por: Pesa, Jacqueline A, et al.
Publicado: (2012)

Prescribing of Antipsychotic Medication in a Medicaid Population: Use of Polytherapy and Off-Label Dosages
por: Kogut, Stephen J., et al.
Publicado: (2005)

Stroke nurse navigator utilization reduces unplanned 30-day readmission in stroke patients treated with thrombolysis
por: Jun-O'Connell, Adalia H., et al.
Publicado: (2023)

A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
por: Lin, Dee, et al.
Publicado: (2023)

Case Selection for a Medicaid Chronic Care Management Program
por: Weir, Sharada, et al.
Publicado: (2008)

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
por: Nadkarni, Anagha, et al.
Publicado: (2013)

PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia
por: Pesa, J., et al.
Publicado: (2021)

The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)

Differences in Medicaid Antipsychotic Medication Measures Among Children with SSI, Foster Care, and Income-Based Aid
por: Leckman-Westin, Emily, et al.
Publicado: (2018)

Trends in Medicaid Prescription Drug Utilization and Payments, 1990-97
por: Baugh, David K., et al.
Publicado: (1999)

Drug utilization and cost in a Medicaid population: A simulation study of community vs. mail order pharmacy
por: Valluri, Satish, et al.
Publicado: (2007)

Delayed Presentation of Antipsychotic Withdrawal Tardive Dyskinesia: A Case Report
por: Solanki, Siddhant, et al.
Publicado: (2023)

Preferred drug lists: Potential impact on healthcare economics
por: Ovsag, Kimberly, et al.
Publicado: (2008)

Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial
por: Henderson, Catherine, et al.
Publicado: (2015)

Medicaid Drugs
por: Poisal, John A.
Publicado: (2004)

Long-term acute care hospitals and Georgia Medicaid: Utilization, outcomes, and cost
por: Cole, Evan S., et al.
Publicado: (2016)

Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan
por: Corelli, Robin L., et al.
Publicado: (2021)

Patient Preference for Antiepileptic Drugs Treatment in China: Evidence From the Discrete Choice Experiment
por: Hua, Yingjie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nli4kv26if2o73eng537c0h4k7